Thyrocare Technologies share price
You have to be logged in to add this to Watchlist.- ₹1,023.40(3.96%)June 13, 2025 15:29:01 PM IST
- NSE
- BSE
- Vol : 110.00K (NSE + BSE)Last 20 day avg : 88.28 K
Thyrocare Technologies is trading 3.96% upper at Rs 1,023.40 as compared to its last closing price. Thyrocare Technologies has been trading in the price range of 1,028.90 & 971.05. Thyrocare Technologies has given 8.04% in this year & -1.16% in the last 5 days. Thyrocare Technologies has TTM P/E ratio 39.38 as compared to the sector P/E of 23.24.There are 1 analysts who have initiated coverage on Thyrocare Technologies. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 21.70 Crores in its last quarter.Listed peers of Thyrocare Technologies include Healthcare Global Enterprises (0.89%), Kovai Medical Cente And Hospital (-0.69%), Thyrocare Technologies (3.96%).The Mutual Fund holding in Thyrocare Technologies was at 12.97% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Thyrocare Technologies was at 2.41% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Jun 13, 2025, 01:27 PM UTC
- Dividend YieldHigher than industry2.13Annual dividends as a percentage of the stock price.
- P/BHigher than historical values9.55The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values57.24Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.80Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.05The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 21.34% from Rs 187.16 crore to Rs 154.25 crore, year-on-year
- The company has grown its March quarter profit by 22.05% from Rs 17.78 crore to Rs 21.70 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 1,122.78
- R2
- 1,195.22
- R3
- 1,317.98
- S1
- 927.58
- S2
- 804.82
- S3
- 732.38
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Healthcare Global Enterprises | Bullish | 549.60 | 0.89 | 7,676.26 | 173.79 | 8.25 | - | 149.57 |
| Kovai Medical Cente And Hospital | Neutral | 5,937.00 | -0.69 | 6,495.39 | 31.66 | 6.09 | 0.17 | 34.88 |
| Thyrocare Technologies | Bullish | 1,023.40 | 3.96 | 5,403.88 | 58.27 | 9.65 | 1.81 | 3.09 |
| Indraprastha Medical Corp | Bearish | 409.25 | -0.46 | 3,755.75 | 24.05 | 6.49 | 1.07 | 5.12 |
| Artemis Medicare Services | Bearish | 260.40 | 0.04 | 3,625.88 | 49.95 | 4.36 | 0.17 | 29.74 |
Pledged found - Promoter(s) have pledged 100.00% of shares.- Pledging Flat - Promoter(s) pledging has not increased in last quarter.
- Promoter(s) holds a high stake in the company at 71.06%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding has decreased by 0.36 percentage points from previous quarter
- Mutual Funds holding has increased by 0.22 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| 2024-07-23 | Quarterly Results |
| 2024-05-14 | Audited Results & Final Dividend |
- IndustryHealthcare Facilities
- ISININE594H01019
- BSE Code539871
- NSE CodeTHYROCARE
Thyrocare Technologies is trading at 1023.40 as on Fri Jun 13 2025 09:59:01. This is 3.96% upper as compared to its previous closing price of 984.40.
The market capitalization of Thyrocare Technologies is 5403.88 Cr as on Fri Jun 13 2025 09:59:01.
The average broker rating on Thyrocare Technologies is Strong Buy. The breakup of analyst rating is given below -
- 1 analysts have given a strong buy rating
- 0.00 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Thyrocare Technologies is 1072.45 whereas the 52 wk low is 605.05
Thyrocare Technologies can be analyzed on the following key metrics -
- TTM P/E: 39.38
- Sector P/E: 23.24
- Dividend Yield: 2.13%
- D/E ratio: 0.05
Thyrocare Technologies reported a net profit of 91.51 Cr in 2025.
The Mutual Fund Shareholding was 12.97% at the end of 31 Mar 2025.